Poukalov Konstantin has filed 5 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 30000 shares of Lyra Therapeutics, Inc. ($LYRA) on June 13, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 13, 2024 | Lyra Therapeutics, Inc. | $LYRA | Poukalov Konstantin | Not found | A | Stock Option | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 15, 2024 | LianBio | $LIANY | Poukalov Konstantin | Director | M | Ordinary Shares | 36300 | $2.52 | 36,300.0000 | 107,167,691 | 9999.99% | 0.03% |
| Feb. 15, 2024 | LianBio | $LIANY | Poukalov Konstantin | Director | F | Ordinary Shares | 19218 | $4.76 | 17,082.0000 | 107,167,691 | 52.94% | 0.02% |
| Feb. 15, 2024 | LianBio | $LIANY | Poukalov Konstantin | Director | M | Stock Option (Right to Buy) | 36300 | $0.00 | 0.0000 | 107,167,691 | 100.00% | 0.03% |
| June 30, 2023 | Lyra Therapeutics, Inc. | $LYRA | Poukalov Konstantin | Not found | A | Stock Option | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |